Eap CB - Search Results

1

Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.

Dobrinas M, Crettol S, Oneda B, Lahyani R, Rotger M, Choong E, Lubomirov R, Csajka C, Eap CB. Dobrinas M, et al. Among authors: eap cb. Pharmacogenet Genomics. 2013 Feb;23(2):84-93. doi: 10.1097/FPC.0b013e32835cb2e2. Pharmacogenet Genomics. 2013. PMID: 23249875

2

CYP3A activity measured by the midazolam test is not related to 3435 C >T polymorphism in the multiple drug resistance transporter gene.

Eap CB, Fellay J, Buclin T, Bleiber G, Golay KP, Brocard M, Baumann P, Telenti A. Eap CB, et al. Pharmacogenetics. 2004 Apr;14(4):255-60. doi: 10.1097/00008571-200404000-00005. Pharmacogenetics. 2004. PMID: 15083070

3

Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.

Bondolfi G, Morel F, Crettol S, Rachid F, Baumann P, Eap CB. Bondolfi G, et al. Among authors: eap cb. Ther Drug Monit. 2005 Aug;27(4):539-43. doi: 10.1097/01.ftd.0000164609.14808.93. Ther Drug Monit. 2005. PMID: 16044115

4

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.

Crettol S, Déglon JJ, Besson J, Croquette-Krokkar M, Gothuey I, Hämmig R, Monnat M, Hüttemann H, Baumann P, Eap CB. Crettol S, et al. Among authors: eap cb. Clin Pharmacol Ther. 2005 Dec;78(6):593-604. doi: 10.1016/j.clpt.2005.08.011. Clin Pharmacol Ther. 2005. PMID: 16338275 Clinical Trial.

5

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.

Widmer N, Decosterd LA, Csajka C, Leyvraz S, Duchosal MA, Rosselet A, Rochat B, Eap CB, Henry H, Biollaz J, Buclin T. Widmer N, et al. Among authors: eap cb. Br J Clin Pharmacol. 2006 Jul;62(1):97-112. doi: 10.1111/j.1365-2125.2006.02719.x. Br J Clin Pharmacol. 2006. PMID: 16842382 Free PMC article.

6

ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.

Crettol S, Déglon JJ, Besson J, Croquette-Krokar M, Hämmig R, Gothuey I, Monnat M, Eap CB. Crettol S, et al. Among authors: eap cb. Clin Pharmacol Ther. 2006 Dec;80(6):668-81. doi: 10.1016/j.clpt.2006.09.012. Clin Pharmacol Ther. 2006. PMID: 17178267

7

Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers.

Eap CB, Crettol S, Rougier JS, Schläpfer J, Sintra Grilo L, Déglon JJ, Besson J, Croquette-Krokar M, Carrupt PA, Abriel H. Eap CB, et al. Clin Pharmacol Ther. 2007 May;81(5):719-28. doi: 10.1038/sj.clpt.6100120. Epub 2007 Feb 28. Clin Pharmacol Ther. 2007. PMID: 17329992

8

Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression?

Crettol S, Monnat M, Eap CB. Crettol S, et al. Among authors: eap cb. Crit Care. 2007;11(1):119. doi: 10.1186/cc5699. Crit Care. 2007. PMID: 17338832 Free PMC article.

9

Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients.

Uehlinger C, Crettol S, Chassot P, Brocard M, Koeb L, Brawand-Amey M, Eap CB. Uehlinger C, et al. Among authors: eap cb. J Clin Psychopharmacol. 2007 Jun;27(3):273-8. doi: 10.1097/JCP.0b013e3180592ad2. J Clin Psychopharmacol. 2007. PMID: 17502774 Clinical Trial.

10

In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites.

Crettol S, Digon P, Golay KP, Brawand M, Eap CB. Crettol S, et al. Among authors: eap cb. Pharmacology. 2007;80(4):304-11. doi: 10.1159/000107104. Epub 2007 Aug 9. Pharmacology. 2007. PMID: 17690563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters